Davide Pareyson, MD

Carlo Besta Neurological Institute
Milan, Italy

Dr. Davide Pareyson contributed to: definition of phenotype-genotype correlation in CMT, clinical description of novel CMT subtypes and novel mutations, studies on pathomechanisms of late-onset axonal neuropathies related to MPZ mutations, coordination or participation in clinical trials and natural history studies, development of clinical outcome assessments, clinical trial design. Member of the Inherited Neuropathy Consortium; coordinator of the Italian CMT Registry. previously chair of the CMTR; chair of the Peripheral Nerve Working Group of the EURO-NMD ERN.